Health Outcome Predictive Evaluation for COVID 19 international registry (HOPE COVID-19), rationale and design

Iván J. Núñez‐Gil(Hospital Clínico San Carlos), Carlos Macaya(Universidad Complutense de Madrid), Harish Ramakrishna(Mayo Clinic in Arizona), Jia Huang(Shenzhen Third People’s Hospital), Carlos E. Vergara-Uzcategui(Hospital Clínico San Carlos), Fabrizio D’Ascenzo(University of Padua), Sergio Raposeiras‐Roubín(University Hospital Complex Of Vigo), Enrico Cerrato(Ospedale San Luigi Gonzaga), Antonio Fernández‐Ortíz(Hospital Clínico San Carlos), Cristina Fernández(Universidad Complutense de Madrid), Gil-Higes Emma(Madrid Health Service), Gisela Feltes(Universidad Europea de Madrid), Francisco Javier Martín‐Sánchez(Universidad Complutense de Madrid), Emilio Alfonso‐Rodríguez, Vicente Estrada(Instituto de Salud Carlos III), Víctor H. Moreno(Hospital Clínico San Carlos), Óscar Vedia(Hospital Clínico San Carlos)
Contemporary Clinical Trials Communications
September 23, 2020
10.1016/j.conctc.2020.100654
Cited by 15

Related Papers

Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy
|JAMA|2016|1.4k
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
|The Lancet|2019|1k
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
|JAMA|2021|728
European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism
|European Heart Journal|2018|435
The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial
|The Lancet|2006|343